Aug 08, 2024 / 08:30PM GMT
Operator
Good afternoon, everyone, and thank you for joining OptimizeRx's second-quarter fiscal 2024 earnings call.
With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Chief Financial Officer, Ed Stelmakh; President, Steve Silvestro; General Counsel, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva.
At the conclusion of today's earnings call, I will provide important cautions regarding the forward-looking statements made by management during today's call. I would like to remind everyone that today's call is being recorded, and will be made available for replay via webcast only. Instructions are included in today's press release and in the Investors section of the company's website.
Now I'd like to turn the call over to OptimizeRx CEO, William Febbo. Sir, please go ahead.
William Febbo - OPTIMIZERx Corp - Chief Executive Officer, Director
Thank you, operator, and good afternoon to everyone joining today's second-quarter 2024 earnings call.
While we welcome 36%
Q2 2024 OptimizeRx Corp Earnings Call Transcript
Aug 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers